Skip to main content

Table 2 The seroprevalence of HGA in different tick exposure risk groups in Europe

From: A review on the eco-epidemiology and clinical management of human granulocytic anaplasmosis and its agent in Europe

Country

Location

Prevalence (%)

Total examined

Group

Method

References

Austria

Tyrol

2.62

191

TBD suspected

IFAT

[94]

Belgium

30.96

1350

TBD suspected

IFAT

[96]

Belgium

Walloon

14.20

148

Exposed workers

ELISA

[82]

Namur

17.20

209

Blood donors

Brussels

14.50

193

Blood donors

Czech Republic

Central Bohemia

15.15

66

EM patients

PCR; Seq

[100]

18.18

66

EM patients

IFAT

France

0.01

141,007

 

IFAT

[125]

1.01

399

 

PCR

France

Alsace

20.00

15

 

IFAT; PCR

[102]

France

Alsace

2.60

2908

Forest workers

ELISA

[123]

Lorraine

1.30

Champagne-Ardenne

1.40

Bourgogne

1.00

Franche-Comté

2.30

Germany

4.51

422

Ab to B. burgdorferi

IFAT

[104]

1.20

249

Control group

IFAT

Italy

6.33

79

 

IFAT

[105]

Norway

Telemark

10.34

58

LB patients

IFAT

[107]

1.96

51

Control group

Norway

Sogn og Fjordane

16.28

301

Blood donors

IFAT

[127]

Poland

Pulawy

26.10

46

Forest workers

IFAT

[122]

Lubartów

35.90

39

Lublin

23.30

30

Sobibór

17.00

47

Zwierzyniec

23.60

55

Goscieradów

13.60

44

Lublin

5.4

56

Blood donors

Poland

Lublin

20.63

63

Forest workers

IFAT

[119]

Poland

9.1

450

Endemic area

IFAT

[120]

2

50

Blood donors

Poland

Białystok

3.9

231

Forest workers

IFAT

[121]

Poland

Roztocze

17.7

113

Forest workers

IFAT

[76]

Lublin

5.4

56

Blood donors

Poland

10.91

110

TBE

PCR

[110]

Slovakia

25

76

TBD suspected

IFAT

[111]

Slovenia

60.87

46

 

PCR; Seq

[32]

Sweden

Koster Island

11.35

185

 

IFAT

[114]

Sweden

9.70

206

TBD suspected

IFAT

[116]

Switzerland

0.54

373

Newborns

IFAT

[81]

1.13

530

Blood donors

8.91

258

Hunters

12.75

149

Ab to B. burgdorferi

19.51

205

Ab to TBE

  1. Abbreviations: Ab, antibody; TBD, tick borne disease; EM, erythema migrans; LB, Lyme borreliosis; Seq, sequencing